{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:35:16Z","timestamp":1787240116245,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX002829"],"award-info":[{"award-number":["BX002829"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jneuroim.2025.578673","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T01:00:32Z","timestamp":1750208432000},"page":"578673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Therapeutic potential of S-nitrosoglutathione reductase inhibitor in B cell-driven experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"406","author":[{"given":"Jeseong","family":"Won","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avtar K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inderjit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2025.578673_bb0005","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0010","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20111675","article-title":"B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells","volume":"209","author":"Barr","year":"2012","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0015","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1016\/j.bbagen.2013.02.004","article-title":"S-nitrosoglutathione","volume":"1830","author":"Broniowska","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.21944","article-title":"Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis","volume":"67","author":"Correale","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0039-6060(98)70113-8","article-title":"Differential effects of nitric oxide-mediated S-nitrosylation on p50 and c-jun DNA binding","volume":"124","author":"Delatorre","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0030","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.21652","article-title":"T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-beta","volume":"65","author":"Durelli","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0035","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0040","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.4049\/jimmunol.181.7.4648","article-title":"Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis","volume":"181","author":"Furtado","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1124\/mi.3.5.253","article-title":"S-nitrosylation signaling in cell biology","volume":"3","author":"Gaston","year":"2003","journal-title":"Mol. Interv."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2016.05.002","article-title":"Direct measurement of actual levels of nitric oxide (NO) in cell culture conditions using soluble NO donors","volume":"9","author":"He","year":"2016","journal-title":"Redox Biol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","article-title":"Role of the innate and adaptive immune responses in the course of multiple sclerosis","volume":"14","author":"Hemmer","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0060","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.immuni.2014.02.012","article-title":"Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses","volume":"40","author":"Joller","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0065","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029025","article-title":"Effector T cells in multiple sclerosis","volume":"8","author":"Kaskow","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0070","doi-asserted-by":"crossref","first-page":"30667","DOI":"10.1074\/jbc.M705929200","article-title":"NOS2 regulation of NF-kappaB by S-nitrosylation of p65","volume":"282","author":"Kelleher","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0075","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1084\/jem.176.5.1355","volume":"176","author":"Khoury","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0080","article-title":"STAT3 regulation by S-Nitrosylation: implication for inflammatory disease","author":"Kim","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102053","article-title":"Regulation of B cell functions by S-nitrosoglutathione in the EAE model","volume":"45","author":"Kim","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020482","article-title":"T helper cells: the modulators of inflammation in multiple sclerosis","volume":"9","author":"Kunkl","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0095","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.4049\/jimmunol.1300822","article-title":"The role of CD8+ T cells and their local interaction with CD4+ T cells in myelin oligodendrocyte glycoprotein35-55-induced experimental autoimmune encephalomyelitis","volume":"191","author":"Leuenberger","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0100","doi-asserted-by":"crossref","first-page":"1033159","DOI":"10.3389\/fnmol.2022.1033159","article-title":"Characterization of spleen and lymph node cell types via CITE-seq and machine learning methods","volume":"15","author":"Li","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0105","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L","article-title":"Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein","volume":"32","author":"Lyons","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0110","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1073\/pnas.0403034101","article-title":"S-nitrosylation: physiological regulation of NF-kappaB","volume":"101","author":"Marshall","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0115","doi-asserted-by":"crossref","first-page":"13992","DOI":"10.1073\/pnas.0504979102","article-title":"Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology","volume":"102","author":"Marta","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2018.11.008","article-title":"Regulatory and effector B cells: friends or foes?","volume":"93","author":"Matsushita","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0125","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jaci.2015.12.1319","article-title":"A novel splenic B1 regulatory cell subset suppresses allergic disease through phosphatidylinositol 3-kinase-Akt pathway activation","volume":"138","author":"Matsushita","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11481-009-9187-x","article-title":"S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis","volume":"5","author":"Nath","year":"2010","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0135","doi-asserted-by":"crossref","first-page":"15478","DOI":"10.1073\/pnas.0703725104","article-title":"Nitric oxide induces CD4+CD25+ Foxp3 regulatory T cells from CD4+CD25 T cells via p53, IL-2, and OX40","volume":"104","author":"Niedbala","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0140","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4049\/jimmunol.1202580","article-title":"Nitric oxide-induced regulatory T cells inhibit Th17 but not Th1 cell differentiation and function","volume":"191","author":"Niedbala","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/glia.20436","article-title":"GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions","volume":"55","author":"Prasad","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0150","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41467-021-22230-z","article-title":"The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5","volume":"12","author":"Radomir","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0155","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3389\/fimmu.2020.01884","article-title":"Regulatory B cells and its role in central nervous system inflammatory demyelinating diseases","volume":"11","author":"Ran","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.freeradbiomed.2018.04.558","article-title":"S-nitrosoglutathione reductase (GSNOR) inhibitor as an immune modulator in experimental autoimmune encephalomyelitis","volume":"121","author":"Saxena","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fimmu.2014.00046","article-title":"Regulatory T cells as immunotherapy","volume":"5","author":"Singer","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0170","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.imbio.2018.06.003","article-title":"Regulation of IL-10 and IL-17 mediated experimental autoimmune encephalomyelitis by S-nitrosoglutathione","volume":"223","author":"Singh","year":"2018","journal-title":"Immunobiology"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2024.11.025","article-title":"The role of S-nitrosoglutathione reductase (GSNOR) in T cell-mediated immunopathology of experimental autoimmune encephalomyelitis (EAE)","volume":"564","author":"Singh","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0180","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/WCO.000000000000563","article-title":"B cells in multiple sclerosis","volume":"31","author":"Sospedra","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0185","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/labinvest.2008.53","article-title":"Autoantibodies and neurodegeneration in multiple sclerosis","volume":"88","author":"Vyshkina","year":"2008","journal-title":"Lab. Investig."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0190","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0195","first-page":"117","article-title":"B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms","volume":"6","author":"Wilson","year":"2012","journal-title":"Biologics"},{"key":"10.1016\/j.jneuroim.2025.578673_bb0200","article-title":"Mechanisms of oxidative damage in multiple sclerosis and a cell therapy approach to treatment","volume":"2011","author":"Witherick","year":"2010","journal-title":"Autoimmune Dis."},{"key":"10.1016\/j.jneuroim.2025.578673_bb0205","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","article-title":"Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice","volume":"184","author":"Wolf","year":"1996","journal-title":"J. Exp. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825001547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T21:54:28Z","timestamp":1753134868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825001547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":41,"alternative-id":["S0165572825001547"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578673","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of S-nitrosoglutathione reductase inhibitor in B cell-driven experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578673","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578673"}}